Belpointe Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $892K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $215K | Buy |
|
|||||
|
2024
Q1 | $208K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $193K | Buy |
|
|||||
|
2022
Q4 | $151K | Sell |
|
|||||
|
2022
Q3 | $167K | Buy |
|
|||||
|
2022
Q2 | $148K | Sell |
|
|||||
|
2022
Q1 | $185K | Sell |
|
|||||
|
2021
Q4 | $240K | Sell |
|
|||||
|
2021
Q3 | $243K | Buy |
|
|||||
|
2021
Q2 | $160K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $115K | Sell |
|
|||||
|
2020
Q3 | $103K | Sell |
|
|||||
|
2020
Q2 | $180K | Buy |
|
|||||
|
2020
Q1 | $146K | Sell |
|
|||||
|
2019
Q4 | $686K | Buy |
|
|||||
|
2019
Q3 | $252K | Sell |
|
|||||
|
2019
Q2 | $248K | Buy |
|
|||||
|
2019
Q1 | $189K | Buy |
|
|||||
|
2018
Q4 | $121K | Sell |
|
|||||
|
2018
Q3 | $660K | Buy |
|
|||||
|
2018
Q2 | $455K | Buy |
|
|||||
|
2018
Q1 | $418K | Sell |
|
|||||
|
2017
Q4 | $392K | Buy |
|
|||||
|
2017
Q3 | $354K | Buy |
|